- Home
- EWTX vs WERN Comparison
EWTX vs WERN Comparison
Compare EWTX & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- WERN
- Stock Information
- Founded
- EWTX 2017
- WERN 1956
- Country
- EWTX United States
- WERN United States
- Employees
- EWTX N/A
- WERN N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- WERN Trucking Freight/Courier Services
- Sector
- EWTX Health Care
- WERN Industrials
- Exchange
- EWTX Nasdaq
- WERN Nasdaq
- Market Cap
- EWTX 1.5B
- WERN 1.7B
- IPO Year
- EWTX 2021
- WERN N/A
- Fundamental
- Price
- EWTX $14.06
- WERN $28.55
- Analyst Decision
- EWTX Buy
- WERN Hold
- Analyst Count
- EWTX 9
- WERN 13
- Target Price
- EWTX $39.89
- WERN $31.08
- AVG Volume (30 Days)
- EWTX 804.3K
- WERN 595.2K
- Earning Date
- EWTX 11-06-2025
- WERN 10-28-2025
- Dividend Yield
- EWTX N/A
- WERN 1.97%
- EPS Growth
- EWTX N/A
- WERN N/A
- EPS
- EWTX N/A
- WERN 0.85
- Revenue
- EWTX N/A
- WERN $2,965,642,000.00
- Revenue This Year
- EWTX N/A
- WERN $1.11
- Revenue Next Year
- EWTX N/A
- WERN $5.68
- P/E Ratio
- EWTX N/A
- WERN $33.51
- Revenue Growth
- EWTX N/A
- WERN N/A
- 52 Week Low
- EWTX $10.60
- WERN $23.02
- 52 Week High
- EWTX $38.12
- WERN $42.48
- Technical
- Relative Strength Index (RSI)
- EWTX 46.82
- WERN 51.87
- Support Level
- EWTX $13.69
- WERN N/A
- Resistance Level
- EWTX $15.16
- WERN $28.78
- Average True Range (ATR)
- EWTX 0.68
- WERN 0.68
- MACD
- EWTX -0.11
- WERN -1.08
- Stochastic Oscillator
- EWTX 17.81
- WERN 96.06
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.